BGBaldev Raj Gulati

Baldev Raj Gulati

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Baldev Raj Gulati has a total of 34 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Effectiveness of the PPR Sungri-96 Vaccine in Sheep and Goats in India: A Nationwide Post-Vaccination Seromonitoring Study Towards PPR Elimination

    by Vinayagamurthy Balamurugan, Kirubakaran Vinod Kumar, Rakshit Ojha, Ponnidurai Malini, Ramachandra Deshpande, Prajakta Prashant Bokade, Annett Helcita Dsouza, Shweta Priya, Anand Asha, Archana Pal, et al.

    India launched a nationwide Peste des Petits Ruminants (PPR) Eradication Programme in 2023 with the objective of achieving countrywide control and elimination of PPR by 2030, adapting a systematic mass vaccination, surveillance, and seromonitoring strategy in alignment with the WOAH/FAO Global Control and Eradication Strategy (GCES) under the PPR Global Eradication Programme (PPR-GEP) 2030. As part of the first round of mass vaccination, the present study evaluates the effectiveness of the PPR Sungri-96 (Lineage IV) vaccine in sheep and goats in fields across all the states in India, with particular emphasis on the post-vaccination evaluation (PVE) as per WOAH guidelines. A total of 24,542 post-vaccination (30–90 days) serum samples were collected from sheep and goats aged 6–12 months from 2528 epidemiological units (epi-units, villages) across 24 states of India, following GCES guidelines. Sampling was conducted according to state vaccination schedules during January 2023–December 2024, ensuring appropriate post-vaccination immune-response windows. Serum samples were analysed to detect PPR virus (PPRV)-specific antibodies using the native PPR competitive ELISA (c-ELISA) kit. The study demonstrated an overall post-vaccination seroconversion rate of 69.3% (95% CI: 68.7–69.8%) among small ruminants, indicating a substantial vaccine-induced immune response under field conditions in the target age group with desirable vaccine effectiveness. Exceptionally high post-vaccination seroconversion was observed in Telangana (91.6%) and Andhra Pradesh (82.3%), reflecting effective implementation of vaccination campaigns in these two states. Overall, 61% (1553/2528) of the evaluated epi-units recorded 70% seroconversion post vaccination, whereas 22% (510/2287) of epi-units showed ≥70% seroprevalence pre vaccination in sheep and goats aged 6 to 12 months. These findings demonstrate the effectiveness of the PPR Sungri-96 vaccine in inducing protective immunity under field conditions in accordance with GCES guidelines. The observed inter-state variations in immune response may be attributed to differences in vaccination coverage, implementation efficiency, animal demographics, husbandry practices, and local epidemiological conditions. However, some states failed to achieve the desired level of post-vaccination immunity, indicating the need for intensified vaccination efforts and improved campaign implementation in such regions. Continued mass vaccination, strengthened surveillance, real-time disease monitoring, farmer awareness programs, and capacity-building initiatives for veterinary services are critical for improving vaccine effectiveness and accelerating progress towards a PPR-free India. This study provides important field evidence supporting the effectiveness of the PPR Sungri-96 vaccine and contributes significantly to both national and global PPR eradication initiatives.

  • Open Access

    Assessment of Population Immunity Against Peste des Petits Ruminants in Goats and Sheep in India After the Second Annual Mass Vaccination Implemented Under the National PPR Eradication Programme

    by Kirubakaran Vinod Kumar, Rakshit Ojha, Ramachandra Deshpande, Shweta Priya, Akshatha Lokanath Goudar, Umathul Ayesha, Ponnidurai Malini, Prajakta Prashant Bokade, Anand Asha, Gangarajareddy Deekshitha, et al.

    This study evaluated population immunity against peste des petits ruminants (PPR) in sheep and goats in India following the second annual round of mass vaccination conducted under the National PPR Eradication Programme (PPR EP), launched in 2023 in accordance with the national strategic plan. A cross-sectional post-vaccination evaluation (PVE) was conducted during August 2024 and April 2026 to assess the herd or population immunity under field conditions, in line with the WOAH and FAO Global Control and Eradication Strategy (GCES) of the PPR Global Eradication Programme (PPR GEP) 2030. A total of 52,133 serum samples were collected within 90 days post vaccination from sheep and goats across three age groups, 6–12 months (n = 18,002), 1–2 years (n = 17,316), and >2 years (n = 16,842), representing 1666 epidemiological units across multiple taluks and districts in 20 Indian states and Union Territories. Serum samples were tested for antibodies against PPR virus using in-house IVRI developed hemagglutinin (H) protein monoclonal antibody based competitive ELISA. The study revealed an overall population immunity of 72%, with age-wise PPRV antibody prevalence of 70.8%, 71.8%, and 72.6% in the 6–12-month, 1–2-year, and >2-year age groups, respectively. Statistical analysis showed significant associations (p < 0.005) between PPRV seropositivity and host factors, including species. Population immunity increased markedly from 41% (pre-vaccination sero-prevalence) in 2023 to nearly 72% by 2025-26 following two consecutive rounds of annual vaccination, accompanied by a substantial reduction in confirmed outbreaks from 57 during 2023 to 20 in 2025 in these 20 states/Union Territories. Notably, about 14.5% of epidemiological units remained below 30% seroprevalence, indicating targeted gaps requiring intensified vaccination. Overall animal vaccination coverage exceeded 95% among small ruminants aged above four months, approaching the population immunity threshold of 70 to 80%. These findings highlight the critical role of sustained successive mass vaccination campaigns in achieving and maintaining protective herd/population immunity, thereby supporting national and global PPR eradication goals.


  • Open Access

    Integrated computational analysis for Escherichia coli prevalence, genetic evolution, and antimicrobial resistance evolution: Implications for public health and environmental sustainability in Asia

    by Ashwini Mallappa, Kuralayanapalya Puttahonnappa Suresh, Sharanagouda S. Patil, Shivasharanappa Nayakvadi, Baldev Raj Gulati, Raghavendra G. Amachawadi, Sudarshan Peramachanahalli Venkatesh, Yamini Sri Sekar, Archana Veeranagouda Patil